⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2015380 | 0.66 | SIGMAR1 (0.33) | — | |
| SCHEMBL13730263 | 0.64 | — | — | |
| SCHEMBL15594537 | 0.59 | — | — | |
| SCHEMBL3656998 | 0.59 | — | — | |
| SCHEMBL3071629 | 0.58 | — | — | |
| SCHEMBL13895039 | 0.58 | — | — | |
| SCHEMBL2017128 | 0.58 | SIGMAR1 (0.36) | — | |
| SCHEMBL85855 | 0.55 | — | — | |
| SCHEMBL1755688 | 0.55 | CA1 (0.35) | — | |
| SCHEMBL239626 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1680420-A4 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS INC (US) | 2008-09-24 | — | — | EP | disclosed |
| EP-1680420-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | Cytokinetics, Inc. (US) | 2006-07-19 | — | — | EP | disclosed |
| US-20050148593-A1 | Treating cell proliferation disorder, anticancer agents | CYTOKINETICS, INC. | 2005-07-07 | — | — | US | disclosed |
| WO-2005046588-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS, INC. (US) | 2005-05-26 | — | — | WO | disclosed |